Comparative Pharmacology
Head-to-head clinical analysis: ALPHAREDISOL versus HYDROXOMIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALPHAREDISOL versus HYDROXOMIN.
ALPHAREDISOL vs HYDROXOMIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cyanocobalamin (vitamin B12) acts as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. Alpharedisol is a cyanocobalamin formulation that corrects vitamin B12 deficiency.
Hydroxocobalamin is a synthetic form of vitamin B12 that acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. It also acts as a direct scavenger of cyanide ions by binding to them to form cyanocobalamin, which is excreted renally.
Hydroxocobalamin 1 mg intramuscularly once daily for 5-10 days, then 1 mg once monthly for life.
100 mg intramuscularly or deep subcutaneously three times a week.
None Documented
None Documented
1.5 hours in healthy adults; prolonged to 3-6 hours in renal impairment
Terminal elimination half-life approximately 4-6 hours; may extend to 8-12 hours in moderate to severe renal impairment (CrCl <30 mL/min).
Renal (90% as unchanged drug); biliary/fecal (10%)
Primarily renal (80-90% unchanged) with minor biliary/fecal elimination (5-10%); total clearance ~150 mL/min.
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement